BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Monday, December 15, 2025
Home » Topics » In the clinic, BioWorld Asia

In the clinic, BioWorld Asia
In the clinic, BioWorld Asia RSS Feed RSS

In the clinic for April 23, 2024

April 23, 2024
Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Actinogen, Imugen, Taigen.
Read More

In the clinic for April 16, 2024

April 16, 2024
Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Abbisko, Akeso, Henlius, Imugene, Kexing, Transthera.
Read More

In the clinic for April 9, 2024

April 9, 2024
Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Daiichi Sankyo, Innocare, Ractigen, Samsung Bioepis, Yoltech.
Read More

In the clinic for March 26, 2024

March 26, 2024
Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Antengene, Asieris, Innovent, Otsuka, Senhwa, Shaperon, Sosei.
Read More

In the clinic for March 19, 2024

March 19, 2024
Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Bioarctic AB, Immunlabs, Imugene, Recce, Remegen, Takeda.
Read More

In the clinic for March 12, 2024

March 12, 2024
Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications:Akeso, Cynata, Immutep.
Read More

In the clinic for Mar. 5, 2024

March 5, 2024
Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Akeso, Beigene, Innovent, Pharmaust, Recce.
Read More

In the clinic for Feb. 27, 2024

Feb. 27, 2024
Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: CASI, Cellitrion, Everest, Innovent, Kazia, Mabwell, Neurophth, Simcare.
Read More

In the clinic for Feb. 20, 2024

Feb. 20, 2024
Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Alterity, Hutchmed, Iregene, Kyowa Kirin, Olix, Opthea, Otsuka, Takeda.
Read More

In the clinic for Feb. 6, 2024

Feb. 6, 2024
Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Bio-Thera, Qilu.
Read More
Previous 1 2 … 5 6 7 8 9 10 11 12 13 … 31 32 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for Dec. 15, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for Dec. 16, 2025.
  • Acute myeloid leukemia illustration

    Apollo’s APL-4098 shows potent antileukemic effects

    BioWorld Science
    Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
  • Novo Nordisk semaglutide pill

    CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials

    BioWorld
    A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
  • CT scan of brain showing subdural hematoma

    FDA greenlights Medtronic Onyx subdural hematoma treatment

    BioWorld MedTech
    Sometimes the darkest products (names) bring a bright spot of news to their developers, as the U.S. FDA clearance for Galway, Ireland-based Medtronic plc's Onyx...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • NME Digest
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing